Second H10N7 flu challenge for prior participants
Part of Infections, Lungs & breathing clinical trials.
This study tests whether people who have already been exposed to a lab-made H10N7 flu virus can be safely exposed again. It checks how their immune system responds and how long they shed the virus, in a controlled, isolated setting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have taken part in a previous H10N7 flu challenge study.
- You need to be between 18 and 55 years old.
- You must be willing to stay in isolation for at least 9 days and follow all study rules.
- You cannot smoke, vape, or use marijuana during the study.
- You must agree to use effective birth control (if you could become pregnant or get someone pregnant) starting 4 weeks before the study and continuing until the last follow-up visit.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how the body reacts to a specific flu virus (pH1N1) in a controlled setting. Healthy volunteers are exposed to the virus to help researchers understand the infection and test treatments. You will be monitored closely and given antiviral medication if needed.
This study tests an experimental flu vaccine (BPL-1357) in healthy volunteers who will later be exposed to H1N1 flu virus in a controlled setting, to see if the vaccine can prevent or reduce illness.
This trial tests an experimental mRNA flu vaccine in healthy adults ages 18 to 59. Researchers want to see if it is safe and helps the body build protection against the flu.
This study tests how the body responds to a mild, lab-made dengue virus in people who have had dengue before. It looks at how the immune system reacts to a second infection, which may help improve future vaccines and treatments.
This study keeps track of how your body’s immune responses change over time after an influenza exposure. Researchers may use stored blood samples to study specific antibody levels, which could help improve future flu vaccines or treatments.
This study tests how healthy adults respond to being exposed to a flu virus in a controlled setting. You will be closely monitored and may help researchers learn more about flu and potential treatments.
Hear when a new Influenza Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.